Abstract
In February of 1969 the National Jewish Hospital began to use rifampin for treatment of patients with far advanced, multiple drug resistant tuberculosis. It was also used in patients with atypical mycobacterial infections. The initial results have been reported elsewhere.1 This report summarizes the results of rifampin therapy in 136 patients who have been under treatment and followup for 6 to 35 months.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
